Showing results (101-110 of 258) with videos related to

Sort By:
Pageof 26
Oncotarget|June 2, 2018
Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancerGiandomenico Roviello, Silvia Paola Corona, Andrea Giovanni Multari, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2016
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trialsGiandomenico Roviello, Sandra Sigala, Shahneen Sandhu, et al.
Plos One|August 6, 2019
Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinomaAlberto D'Angelo, Navid Sobhani, Giandomenico Roviello, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 15, 2015
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectivesGiandomenico Roviello, Karol Polom, Roberto Petrioli, et al.
Current Issues in Molecular Biology|September 22, 2022
Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity StudyAlberto D'Angelo, Fabiola Giudici, Robert Chapman, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2023
Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory studyFrancesco Schettini, Alessandra Fontana, Federica Gattazzo, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
Neoadjuvant Model in Cancer Treatment: From Clinical Opportunity to Health-Care UtilityDaniele Generali, Stephen B Fox, Massimo Cristofanilli, et al.
Cancers|January 11, 2024
Oral Problems in Oncology Patients Undergoing Chemotherapy for Solid Tumors: A Prospective Observational StudyGiulia Ottaviani, Giada Targato, Katia Rupel, et al.
Cancer Chemotherapy and Pharmacology|December 2, 2025
Impact of adverse events on survival outcomes in patients treated with CDK4/6 inhibitors for advanced breast cancerMartina Catalano, Gestiana Cekrezi, Irene De Gennaro Aquino, et al.
Breast (Edinburgh, Scotland)|June 3, 2026
A mixed prebiotic/probiotic intervention (MBR-01) for the management of diarrhea during abemaciclib treatment of early breast cancer in postmenopausal patients: A single-center prospective case-control pilot studyDaniele Generali, Alexandro Membrino, Alessandra Fontana, et al.
Pageof 26